| Reference |
|---|
Alirzayeva H, Loureiro R, Koyuncu S, Hommen F, Nabawi Y, Zhang W, et al. ALS-FUS mutations cause abnormal PARylation and histone H1.2 interaction, leading to pathological changes. Cell Rep. 2024;43:114626 pubmed publisher |
Chudy P, Kochan J, Wawro M, Nguyen P, Gorczyca M, Varanko A, et al. Heme oxygenase-1 protects cells from replication stress. Redox Biol. 2024;75:103247 pubmed publisher |
Shu Y, Jin X, Ji M, Zhang Z, Wang X, Liang H, et al. Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis. Cancer Res. 2024;84:2836-2855 pubmed publisher |
Saha S, Huang S, Yang X, Saha L, Sun Y, Khandagale P, et al. The TDRD3-USP9X complex and MIB1 regulate TOP3B homeostasis and prevent deleterious TOP3B cleavage complexes. Nat Commun. 2023;14:7524 pubmed publisher |
Wu A, Sekar P, Huang D, Hsu S, Chan C, Lin W. Spatiotemporal roles of AMPK in PARP-1- and autophagy-dependent retinal pigment epithelial cell death caused by UVA. J Biomed Sci. 2023;30:91 pubmed publisher |
Maestri D, Napoletani G, Kossenkov A, Preston Alp S, Caruso L, Tempera I. The three-dimensional structure of the EBV genome plays a crucial role in regulating viral gene expression in EBVaGC. Nucleic Acids Res. 2023;51:12092-12110 pubmed publisher |
Li P, Zhen Y, Kim C, Liu Z, Hao J, Deng H, et al. Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA-mutated cancer. Sci Adv. 2023;9:eadg7752 pubmed publisher |
Li J, Liu X, Peng B, Feng T, Zhou W, Meng L, et al. O-GlcNAc has crosstalk with ADP-ribosylation via PARG. J Biol Chem. 2023;299:105354 pubmed publisher |
Zhu Y, Zhang J, Yan X, Ji Y, Wang F. Exploring a new mechanism between lactate and VSMC calcification: PARP1/POLG/UCP2 signaling pathway and imbalance of mitochondrial homeostasis. Cell Death Dis. 2023;14:598 pubmed publisher |
Chen W, E Q, Sun B, Zhang P, Li N, Fei S, et al. PARP1-catalyzed PARylation of YY1 mediates endoplasmic reticulum stress in granulosa cells to determine primordial follicle activation. Cell Death Dis. 2023;14:524 pubmed publisher |
Wie M, Khim K, Groehler Iv A, Heo S, Woo J, Son K, et al. Alkylation of nucleobases by 2-chloro-N,N-diethylethanamine hydrochloride (CDEAH) sensitizes PARP1-deficient tumors. NAR Cancer. 2023;5:zcad042 pubmed publisher |
Yang S, Hwang S, Kim B, Shin S, Kim M, Jeong S. Fatty acid oxidation facilitates DNA double-strand break repair by promoting PARP1 acetylation. Cell Death Dis. 2023;14:435 pubmed publisher |
Ramos L, Truong S, Zhai B, Joshi J, Ghaidi F, Lizardo M, et al. A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma. Clin Cancer Res. 2023;29:3541-3553 pubmed publisher |
Han C, McNamara B, Bellone S, Harold J, Manara P, Hartwich T, et al. The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo. Gynecol Oncol. 2023;170:172-178 pubmed publisher |
Qi H, Grace Wright R, Beato M, Price B. The ADP-ribose hydrolase NUDT5 is important for DNA repair. Cell Rep. 2022;41:111866 pubmed publisher |
Wang L, Wang D, Sonzogni O, Ke S, Wang Q, Thavamani A, et al. PARP-inhibition reprograms macrophages toward an anti-tumor phenotype. Cell Rep. 2022;41:111462 pubmed publisher |
Abdelghany L, Kawabata T, Goto S, Jingu K, Li T. Nicaraven induces programmed cell death by distinct mechanisms according to the expression levels of Bcl-2 and poly (ADP-ribose) glycohydrolase in cancer cells. Transl Oncol. 2022;26:101548 pubmed publisher |
Deng O, Dash S, Nepomuceno T, Fang B, Yun S, Welsh E, et al. Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian cancer. J Biol Chem. 2022;298:102550 pubmed publisher |
Thakar T, Dhoonmoon A, Straka J, Schleicher E, Nicolae C, Moldovan G. Lagging strand gap suppression connects BRCA-mediated fork protection to nucleosome assembly through PCNA-dependent CAF-1 recycling. Nat Commun. 2022;13:5323 pubmed publisher |
Cahuzac M, P xe9 ant B, Mes Masson A, Saad F. Development of Olaparib-Resistance Prostate Cancer Cell Lines to Identify Mechanisms Associated with Acquired Resistance. Cancers (Basel). 2022;14: pubmed publisher |
Wong W, Crane E, Zhang H, Li J, Day T, Green A, et al. Pgc-1α controls epidermal stem cell fate and skin repair by sustaining NAD+ homeostasis during aging. Mol Metab. 2022;65:101575 pubmed publisher |
Blessing C, Apelt K, van den Heuvel D, González Leal C, Rother M, van der Woude M, et al. XPC-PARP complexes engage the chromatin remodeler ALC1 to catalyze global genome DNA damage repair. Nat Commun. 2022;13:4762 pubmed publisher |
Zhao S, Hong Y, Liang Y, Li X, Shen J, Sun C, et al. Compartmentalized regulation of NAD+ by Di (2-ethyl-hexyl) phthalate induces DNA damage in placental trophoblast. Redox Biol. 2022;55:102414 pubmed publisher |
Zhang Y, Fang M, Li S, Xu H, Ren J, Tu L, et al. BTApep-TAT peptide inhibits ADP-ribosylation of BORIS to induce DNA damage in cancer. Mol Cancer. 2022;21:158 pubmed publisher |
Trulsson F, Akimov V, Robu M, van Overbeek N, Berrocal D, Shah R, et al. Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates. Nat Commun. 2022;13:2736 pubmed publisher |
Linares J, Cid Díaz T, Duran A, Osrodek M, Martínez Ordóñez A, Reina Campos M, et al. The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62. Cell Rep. 2022;39:110792 pubmed publisher |
Liu L, Sandow J, Leslie Pedrioli D, Samson A, Silke N, Kratina T, et al. Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death. Sci Adv. 2022;8:eabh2332 pubmed publisher |
Lin X, Jiang W, Rudolph J, Lee B, Luger K, Zha S. PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites. Nucleic Acids Res. 2022;50:3958-3973 pubmed publisher |
Cahuzac M, Langlois P, P xe9 ant B, Fleury H, Mes Masson A, Saad F. Pre-activation of autophagy impacts response to olaparib in prostate cancer cells. Commun Biol. 2022;5:251 pubmed publisher |
Hou X, Cai C, He Y, An S, Zhao S, Sun H, et al. Protective Effect of Minocycline Hydrochloride on the Mouse Embryonic Development Against Suboptimal Environment. Front Cell Dev Biol. 2022;10:799042 pubmed publisher |
Chen Q, Ma K, Liu X, Chen S, Li P, Yu Y, et al. Truncated PARP1 mediates ADP-ribosylation of RNA polymerase III for apoptosis. Cell Discov. 2022;8:3 pubmed publisher |
Sethy C, Kundu C. PARP inhibitor BMN-673 induced apoptosis by trapping PARP-1 and inhibiting base excision repair via modulation of pol-β in chromatin of breast cancer cells. Toxicol Appl Pharmacol. 2022;436:115860 pubmed publisher |
Sarwar Z, Nabi N, Bhat S, Gillani S, Reshi I, Un Nisa M, et al. Interaction of DBC1 with polyoma small T antigen promotes its degradation and negatively regulates tumorigenesis. J Biol Chem. 2022;298:101496 pubmed publisher |
Cooper K, Volk L, Dominguez D, Duran A, Ke Jian Liu K, Hudson L. Contribution of NADPH oxidase to the retention of UVR-induced DNA damage by arsenic. Toxicol Appl Pharmacol. 2022;434:115799 pubmed publisher |
Park S, Kim Y, Ra J, Wie M, Kang M, Kang S, et al. Timely termination of repair DNA synthesis by ATAD5 is important in oxidative DNA damage-induced single-strand break repair. Nucleic Acids Res. 2021;49:11746-11764 pubmed publisher |
Tromans Coia C, Sanchi A, Moeller G, Timinszky G, Lopes M, Ahel I. TARG1 protects against toxic DNA ADP-ribosylation. Nucleic Acids Res. 2021;49:10477-10492 pubmed publisher |
Sun Y, Chen J, Huang S, Su Y, Wang W, Agama K, et al. PARylation prevents the proteasomal degradation of topoisomerase I DNA-protein crosslinks and induces their deubiquitylation. Nat Commun. 2021;12:5010 pubmed publisher |
Peng B, Shi R, Bian J, Li Y, Wang P, Wang H, et al. PARP1 and CHK1 coordinate PLK1 enzymatic activity during the DNA damage response to promote homologous recombination-mediated repair. Nucleic Acids Res. 2021;49:7554-7570 pubmed publisher |
Oka S, Leon J, Sakumi K, Abolhassani N, Sheng Z, Tsuchimoto D, et al. MTH1 and OGG1 maintain a low level of 8-oxoguanine in Alzheimer's brain, and prevent the progression of Alzheimer's pathogenesis. Sci Rep. 2021;11:5819 pubmed publisher |
Martí J, García Díaz A, Delgado Bellido D, O Valle F, González Flores A, Carlevaris O, et al. Selective modulation by PARP-1 of HIF-1α-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions. Redox Biol. 2021;41:101885 pubmed publisher |
Chung W, Lee S, Kim Y, Seo J, Song M. Kaposi's sarcoma-associated herpesvirus processivity factor (PF-8) recruits cellular E3 ubiquitin ligase CHFR to promote PARP1 degradation and lytic replication. PLoS Pathog. 2021;17:e1009261 pubmed publisher |
Matteini F, Andresini O, Petrai S, Battistelli C, Rossi M, Maione R. Poly(ADP-ribose) Polymerase 1 (PARP1) restrains MyoD-dependent gene expression during muscle differentiation. Sci Rep. 2020;10:15086 pubmed publisher |
Gibson A, Yeung C, Issaq S, Collins V, Gouzoulis M, Zhang Y, et al. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma. Oncogenesis. 2020;9:80 pubmed publisher |
Shao Z, Lee B, Rouleau Turcotte É, Langelier M, Lin X, Estes V, et al. Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo. Nucleic Acids Res. 2020;48:9694-9709 pubmed publisher |
Patidar P, Viera T, Morales J, Singh N, Motea E, Khandelwal M, et al. XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition. Sci Rep. 2020;10:14253 pubmed publisher |
Hanzlikova H, Prokhorova E, Krejcikova K, Cihlarova Z, Kalasová I, Kubovčiak J, et al. Pathogenic ARH3 mutations result in ADP-ribose chromatin scars during DNA strand break repair. Nat Commun. 2020;11:3391 pubmed publisher |
Mao K, Chen J, Yu H, Li H, Ren Y, Wu X, et al. Poly (ADP-ribose) polymerase 1 inhibition prevents neurodegeneration and promotes α-synuclein degradation via transcription factor EB-dependent autophagy in mutant α-synucleinA53T model of Parkinson's disease. Aging Cell. 2020;19:e13163 pubmed publisher |
Calahorra J, Martinez Lara E, Granadino Roldán J, Martí J, Cañuelo A, Blanco S, et al. Crosstalk between hydroxytyrosol, a major olive oil phenol, and HIF-1 in MCF-7 breast cancer cells. Sci Rep. 2020;10:6361 pubmed publisher |
Yang G, Chen Y, Wu J, Chen S, Liu X, Singh A, et al. Poly(ADP-ribosyl)ation mediates early phase histone eviction at DNA lesions. Nucleic Acids Res. 2020;48:3001-3013 pubmed publisher |
Zhang L, Li D. MORC2 regulates DNA damage response through a PARP1-dependent pathway. Nucleic Acids Res. 2019;47:8502-8520 pubmed publisher |
Li N, Wang Y, Neri S, Zhen Y, Fong L, Qiao Y, et al. Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling. Nat Commun. 2019;10:4363 pubmed publisher |
Chen Y, Zhang H, Xu Z, Tang H, Geng A, Cai B, et al. A PARP1-BRG1-SIRT1 axis promotes HR repair by reducing nucleosome density at DNA damage sites. Nucleic Acids Res. 2019;47:8563-8580 pubmed publisher |
Jain A, Agostini L, McCarthy G, Chand S, Ramirez A, Nevler A, et al. Poly (ADP) ribose glycohydrolase can be effectively targeted in pancreatic cancer. Cancer Res. 2019;: pubmed publisher |
Marcar L, Bardhan K, Gheorghiu L, Dinkelborg P, Pfäffle H, Liu Q, et al. Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity. Cell Rep. 2019;27:3422-3432.e4 pubmed publisher |
Echeverri Tirado L, Ghonim M, Wang J, Al Khami A, Wyczechowska D, Luu H, et al. PARP-1 Is Critical for Recruitment of Dendritic Cells to the Lung in a Mouse Model of Asthma but Dispensable for Their Differentiation and Function. Mediators Inflamm. 2019;2019:1656484 pubmed publisher |
Grunewald M, Chen Y, Kuny C, Maejima T, Lease R, Ferraris D, et al. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression. PLoS Pathog. 2019;15:e1007756 pubmed publisher |
Lombard A, Liu C, Armstrong C, D Abronzo L, Lou W, Chen H, et al. Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer. Transl Oncol. 2019;12:871-878 pubmed publisher |
Wang C, Xu W, An J, Liang M, Li Y, Zhang F, et al. Poly(ADP-ribose) polymerase 1 accelerates vascular calcification by upregulating Runx2. Nat Commun. 2019;10:1203 pubmed publisher |
Bian C, Zhang C, Luo T, Vyas A, Chen S, Liu C, et al. NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression. Nat Commun. 2019;10:693 pubmed publisher |
Li M, Tang Y, Li Q, Xiao M, Yang Y, Wang Y. Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2. Oncogene. 2019;38:3488-3503 pubmed publisher |
Nieborowska Skorska M, Sullivan K, Dasgupta Y, Podszywalow Bartnicka P, Hoser G, Maifrede S, et al. Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells. J Clin Invest. 2017;127:2392-2406 pubmed publisher |
Kulkarni A, Oza J, Yao M, Sohail H, Ginjala V, Tomás Loba A, et al. Tripartite Motif-containing 33 (TRIM33) protein functions in the poly(ADP-ribose) polymerase (PARP)-dependent DNA damage response through interaction with Amplified in Liver Cancer 1 (ALC1) protein. J Biol Chem. 2013;288:32357-69 pubmed publisher |
Fenton A, Shirodkar P, Macrae C, Meng L, Koch C. The PARP3- and ATM-dependent phosphorylation of APLF facilitates DNA double-strand break repair. Nucleic Acids Res. 2013;41:4080-92 pubmed publisher |
Yan Q, Xu R, Zhu L, Cheng X, Wang Z, Manis J, et al. BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8. Mol Cell Biol. 2013;33:845-57 pubmed publisher |
Jaspers J, Kersbergen A, Boon U, Sol W, Van Deemter L, Zander S, et al. Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors. Cancer Discov. 2013;3:68-81 pubmed publisher |
